EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida, ... Leukemia 26 (9), 1908-1975, 2012 | 1097 | 2012 |
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols T Kalina, J Flores-Montero, VHJ Van Der Velden, M Martin-Ayuso, ... Leukemia 26 (9), 1986-2010, 2012 | 874 | 2012 |
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ... Leukemia 31 (10), 2094-2103, 2017 | 653 | 2017 |
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma J Flores‐Montero, R de Tute, B Paiva, JJ Perez, S Böttcher, H Wind, ... Cytometry Part B: Clinical Cytometry 90 (1), 61-72, 2016 | 272 | 2016 |
Measurable residual disease by next-generation flow cytometry in multiple myeloma B Paiva, N Puig, MT Cedena, L Rosiñol, L Cordón, MB Vidriales, L Burgos, ... Journal of Clinical Oncology 38 (8), 784-792, 2020 | 243 | 2020 |
Quality assessment program for E uro F low protocols: Summary results of four‐year (2010–2013) quality assurance rounds T Kalina, J Flores‐Montero, Q Lecrevisse, CE Pedreira, ... Cytometry Part A 87 (2), 145-156, 2015 | 167 | 2015 |
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients B Paiva, MT Cedena, N Puig, P Arana, MB Vidriales, L Cordon, ... Blood, The Journal of the American Society of Hematology 127 (25), 3165-3174, 2016 | 159 | 2016 |
Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a … S Matarraz, A López, S Barrena, C Fernandez, E Jensen, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2010 | 116 | 2010 |
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard-and high-risk myeloma I Goicoechea, N Puig, MT Cedena, L Burgos, L Cordón, MB Vidriales, ... Blood, The Journal of the American Society of Hematology 137 (1), 49-60, 2021 | 112 | 2021 |
MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods M Roshal, JA Flores-Montero, Q Gao, M Koeber, J Wardrope, BGM Durie, ... Blood advances 1 (12), 728-732, 2017 | 111 | 2017 |
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC) L Sanoja-Flores, J Flores-Montero, JJ Garcés, B Paiva, N Puig, ... Blood cancer journal 8 (12), 117, 2018 | 108 | 2018 |
Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients F Weerkamp, E Dekking, YY Ng, VHJ Van der Velden, H Wai, S Böttcher, ... Leukemia 23 (6), 1106-1117, 2009 | 104 | 2009 |
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma A Medina, N Puig, J Flores-Montero, C Jimenez, ME Sarasquete, ... Blood cancer journal 10 (10), 108, 2020 | 98 | 2020 |
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy L Sanoja-Flores, J Flores-Montero, N Puig, T Contreras-Sanfeliciano, ... Blood, The Journal of the American Society of Hematology 134 (24), 2218-2222, 2019 | 95 | 2019 |
Utility of CD 54, CD 229, and CD 319 for the identification of plasma cells in patients with clonal plasma cell diseases F Pojero, J Flores‐Montero, L Sanoja, JJ Pérez, N Puig, B Paiva, ... Cytometry Part B: Clinical Cytometry 90 (1), 91-100, 2016 | 73 | 2016 |
CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features M Schmidt-Hieber, M Pérez-Andrés, B Paiva, J Flores-Montero, JJ Perez, ... Haematologica 96 (2), 328, 2011 | 73 | 2011 |
Introduction to the diagnosis and classification of monocytic‐lineage leukemias by flow cytometry S Matarraz, J Almeida, J Flores‐Montero, Q Lécrevisse, V Guerri, A López, ... Cytometry Part B: Clinical Cytometry 92 (3), 218-227, 2017 | 71 | 2017 |
Circulating tumor cells for the staging of patients with newly diagnosed transplant-eligible multiple myeloma JJ Garcés, MT Cedena, N Puig, L Burgos, JJ Perez, L Cordon, ... Journal of Clinical Oncology 40 (27), 3151-3161, 2022 | 70 | 2022 |
Fluorochrome choices for multi-color flow cytometry J Flores-Montero, T Kalina, A Corral-Mateos, L Sanoja-Flores, ... Journal of immunological methods 475, 112618, 2019 | 60 | 2019 |
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination JJ Garcés, M Simicek, M Vicari, L Brozova, L Burgos, R Bezdekova, ... Leukemia 34 (2), 589-603, 2020 | 57 | 2020 |